FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer
The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
May 11, 2026
0
3
Search results for fusion
Scientists take crucial step in developing world's first measles treatment
Scientists at La Jolla Institute for Immunology (LJI) are the first in the world to characterize human antibodies capable of neutralizing measles virus. These antibodies bind to key sites on measles virus and prevent the ...
May 7, 2026
0
11
Revealing the unusual ability of a protein involved in lung and thyroid cancer
Research conducted at the National Cancer Research Centre (CNIO) has revealed an unexpected behavior observed in a protein involved in several types of cancer: it manages to self-activate, meaning it gives itself the order ...
Apr 29, 2026
0
6
In myasthenia gravis, surgical removal of the thymus gland proves to be effective and economical
In patients with myasthenia gravis, the surgical removal of the thymus gland, called thymectomy, added "quality adjusted life years" to patients and was also cost-effective in comparison to pharmacological treatment alone, ...
Apr 24, 2026
0
4
New targeted therapy shows promise against aggressive childhood and adult cancers
Researchers at the University of British Columbia Faculty of Medicine have developed a new targeted cancer therapy that can precisely seek out and destroy tumor cells—showing strong results in preclinical studies that bring ...
Apr 23, 2026
0
4
Liver cancer roadmap links tumor hallmarks to treatment, including targetable mutations
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the deadliest cancers worldwide. ...
Apr 16, 2026
0
7
'MitoCatch' delivers healthy mitochondria to diseased cells
Scientists led by Botond Roska at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) have developed MitoCatch, a system that enables targeted delivery of healthy mitochondria to specific cell types affected ...
Apr 15, 2026
0
42
A new way to determine which patients will respond best to bowel cancer treatment
Nearly 10,000 cases of advanced bowel cancer are diagnosed in England each year, with cases in young adults rising. There are limited options for treating advanced bowel cancer. Scientists have now developed an AI-powered ...
Apr 14, 2026
0
11
Lab-grown retina gives gene change clue to rare childhood eye condition
A study using tiny retinas grown in a lab has revealed how subtle changes in a key growth-controlling protein can lead to a condition causing serious eye defects from birth. The findings, published in the journal Biochimica ...
Apr 13, 2026
0
4
PICALM links training and intermittent fasting to new muscle fiber formation
Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and other partner institutions of the German Center for Diabetes Research (DZD) have now identified a previously unknown function of the PICALM ...
Apr 13, 2026
0
5
